Assessment of quality of life and changes in intestinal microbiota in patients with rheumatoid arthritis

Authors

  • Liudmyla Mikulets Higher State Educational Establishment of Ukraine “Bukovinian State Medical University” Theatralna sq., 2, Chernivtsi, Ukraine, 58002, Ukraine https://orcid.org/0000-0002-1729-4151
  • Olena Glubochenko Higher State Educational Establishment of Ukraine “Bukovinian State Medical University” Theatralna sq., 2, Chernivtsi, Ukraine, 58002, Ukraine https://orcid.org/0000-0002-4820-1173
  • Katerina Bobkovych Higher State Educational Establishment of Ukraine “Bukovinian State Medical University” Theatralna sq., 2, Chernivtsi, Ukraine, 58002, Ukraine https://orcid.org/0000-0001-5783-2412
  • Anton Ivanitsky Higher State Educational Establishment of Ukraine „Bukovinian State Medical University” Theatralna sq., 2, Chernivtsi, Ukraine, 58002, Ukraine https://orcid.org/0000-0001-5368-6630

DOI:

https://doi.org/10.15587/2519-4798.2017.109313

Keywords:

rheumatoid arthritis, life quality, specific level, population level, intestinal microbiota

Abstract

Aim. The aim of the work was to study life quality indices depending of degrees of large intestine microflora in patients with rheumatoid arthritis.

Methods. The study was carried out on 43 patients with rheumatoid arthritis and 21 practically healthy persons. To determine the role of intestinal microflora in the rheumatoid genesis in patients with RA, excrements microbiological study was carried out. The comparative assessment of life quality parameters was carried out using SF-36 questionnaire.

Result. In all patients with RA were extracted bifidobacteria, lactobacteria, bacteroides and colon bacillus, at that eubacteria, peptococcus and enterococci were eliminated from their large intestine cavity. On this background the contamination of the large intestine cavity by pathogenic and conventionally pathogenic enterobacteria and also Clostridium bacteria, staphylococci and Candida yeast-like fungi took place. The analysis of  SF-36 questionnaire scales demonstrated that all parameters of patients with RA were lower than in the control group and depended on large intestine cavity microflora changes by certain indices.

Conclusions. In patients with rheumatoid arthritis is observed the change of specific and population level of large intestine cavity microbiota. At dysbiotic disorders in these patients was observed the decrease of life quality indices, especially, ones of the physical health component. The lowest life quality indices were observed in patients with ІІІ degree of microbiological disorders

Author Biographies

Liudmyla Mikulets, Higher State Educational Establishment of Ukraine “Bukovinian State Medical University” Theatralna sq., 2, Chernivtsi, Ukraine, 58002

PhD, Assistant Professor

Department of Propaedeutics Internal Medicine

Olena Glubochenko, Higher State Educational Establishment of Ukraine “Bukovinian State Medical University” Theatralna sq., 2, Chernivtsi, Ukraine, 58002

PhD, Associate Professor

Department of Propaedeutics Internal Medicine

Katerina Bobkovych, Higher State Educational Establishment of Ukraine “Bukovinian State Medical University” Theatralna sq., 2, Chernivtsi, Ukraine, 58002

PhD, Associate Professor

Department of Propaedeutics Internal Medicine

References

  1. Verstappen, S. M. M., Bijlsma, J. W. J., Verkleij, H., Buskens, E., Blaauw, A. A. M. et. al. (2004). Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Care & Research, 51 (3), 488–497. doi: 10.1002/art.20419
  2. Nasonov, E. L. (2004). Revmatoidnyi artrit kak obshchemeditcinskaia problema. Terapevticheskiy arhiv, 5, 5–7.
  3. Amirdzhanova, V. N., Goriachev, D. V., Korshunov, N. I., Rebrov, A. P., Sorotckaia, V. N. (2008). Populiatcionnye pokazateli kachestva zhizni po oprosniku SF-36 (rezultaty mnogotcentrovogo issledovaniia kachestva zhizni “MIRAZh”). Nauchno-prakticheskaya revmatologiya, 1, 38–48.
  4. Bressa, C., Bailen-Andrino, M., Perez-Santiago, J., Gonzalez-Soltero, R., Perez, M., Montalvo-Lominchar, M. G. et. al. (2017). Differences in gut microbiota profile between women with active lifestyle and sedentary women. PLoS ONE, 12 (2), e0171352. doi: 10.1371/journal.pone.0171352
  5. Jeffery, I. B., Lynch, D. B., O’Toole, P. W. (2016). Composition and temporal stability of the gut microbiota in older persons. The ISME Journal, 10 (1), 170–182. doi: 10.1038/ismej.2015.88
  6. Chervonsky, A. V. (2010). Influence of microbial environment on autoimmunity. Nature Immunology, 11 (1), 28–35. doi: 10.1038/ni.1801
  7. Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E. et. al. (2009). A core gut microbiome in obese and lean twins. Nature, 457 (7228), 480–484. doi: 10.1038/nature07540
  8. Chan, C., Wong, R., Law, P., Wong, C., Tsui, S., Tang, W., Sit, J. (2016). Environmental Factors Associated with Altered Gut Microbiota in Children with Eczema: A Systematic Review. International Journal of Molecular Sciences, 17 (7), 1147. doi: 10.3390/ijms17071147
  9. Felice, V. D., Quigley, E. M., Sulliv, A. M., O'Keefe, G. M., O'Mahony, S. M. (2016). Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism & Related Disorders, 27, 1–8. doi: 10.1016/j.parkreldis.2016.03.012
  10. Scher, J. U., Sczesnak, A., Longman, R. S., Segata, N., Ubeda, C., Bielski, C. et. al. (2013). Expansion of intestinal Prevotella copricorrelates with enhanced susceptibility to arthritis. eLife, 2, e01202. doi: 10.7554/elife.01202
  11. Taneja, V. (2014). Arthritis susceptibility and the gut microbiome. FEBS Letters, 588 (22), 4244–4249. doi: 10.1016/j.febslet.2014.05.034
  12. Vaahtovuo, J., Munukka, E., Korkeamaki, M., Luukkainen, R., Toivanen, P. (2008). Fecal microbiota in early rheumatoid arthritis. The Journal of Rheumatology, 35 (8), 1500–1505.
  13. Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D. et. al. (2015). The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nature Medicine, 21 (8), 895–905. doi: 10.1038/nm.3914
  14. Ebringer, A., Rashid, T., Wilson, C. (2010). Rheumatoid arthritis, Proteus, anti-CCP antibodies and Karl Popper. Autoimmunity Reviews, 9 (4), 216–223. doi: 10.1016/j.autrev.2009.10.006
  15. Kharchenko, N. V., Chernenko, V. V. (2000). Suchasni pidkhody do korektsii dysbiozu kyshechnyka. Kyiv, 28.
  16. Mikel'saar, M. E., Snigur, U. H., Lentsner, A. A. (1990). Otsenka kachestvennogo sostava mikroflory fekaliy. Lab. delo, 3, 62–66.
  17. Ware, J. E., Snow, K. K., Kosinski, M., Gandek, B. (1993). SF-36 Health Survey. Boston: The Health Institute, New England Medical Center, 314.
  18. Hammer, O., Harper, D. A. T., Ryan, P. D. (2001). PAST: Paleontological Statistics Software Package for Education and Data Analysis. Palaeontologia Electronica, 4 (1), 9. Available at: http://palaeo-electronica.org/2001_1/past/issue1_01.htm
  19. Piche, T. (2009). Alterations of intestinal epithelial barrier and flora in the irritable bowel syndrome. Gastroenterologie Clinique Et Biologique, 33 (1), 40–47.
  20. De Palma, G., Collins, S. M., Bercik, P., Verdu, E. F. (2014). The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? The Journal of Physiology, 592 (14), 2989–2997. doi: 10.1113/jphysiol.2014.273995
  21. Messaoudi, M., Violle, N., Bisson, J.-F., Desor, D., Javelot, H., Rougeot, C. (2011). Beneficial psychological effects of a probiotic formulation (Lactobacillus helveticusR0052 andBifidobacterium longumR0175) in healthy human volunteers. Gut Microbes, 2 (4), 256–261. doi: 10.4161/gmic.2.4.16108
  22. Ahmed, N., Sechi, L. A., Megraud, F., Hasnain, S. E. (2009). Gut Pathogens: enteric health at the interface of changing microbiology. Gut Pathogens, 1 (1), 1. doi: 10.1186/1757-4749-1-1
  23. Lunia, M. K., Sharma, B. C., Sharma, P., Sachdeva, S., Srivastava, S. (2014). Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial. Clinical Gastroenterology and Hepatology, 12 (6), 1003–1008. doi: 10.1016/j.cgh.2013.11.006
  24. Hemarajata, P., Versalovic, J. (2013). Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therapeutic Advances in Gastroenterology, 6 (1), 39–51. doi: 10.1177/1756283x12459294
  25. O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K. et. al. (2005). Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology, 128 (3), 541–551. doi: 10.1053/j.gastro.2004.11.050
  26. Mikulets, L. V. (2011). Osoblyvosti tsyrkadiannoi orhanizatsii pokaznykiv endohennoi intoksykatsii u krovi khvorykh na revmatoidnyi artryt ta yikh korektsiia za dopomohoiu preparatu enteroshel. Klinichna ta eksperymentalna patolohiia, 2, 59–64.
  27. McCormack, W. J., Parker, A. E., O’Neill, L. A. (2009). Toll-like receptors and NOD-like receptors in rheumatic diseases. Arthritis Research & Therapy, 11 (5), 243. doi: 10.1186/ar2729

Downloads

Published

2017-08-31

How to Cite

Mikulets, L., Glubochenko, O., Bobkovych, K., & Ivanitsky, A. (2017). Assessment of quality of life and changes in intestinal microbiota in patients with rheumatoid arthritis. ScienceRise: Medical Science, (8 (16), 54–59. https://doi.org/10.15587/2519-4798.2017.109313

Issue

No. 8 (16) (2017)

Section

Medical Science

License

Copyright (c) 2017 Liudmyla Mikulets, Olena Glubochenko, Katerina Bobkovych, Anton Ivanitsky

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.